PHARMCO YEAR TO YEAR COMPARISONS
Just take a look at these phenomenal changes
2015
Financials: Unaudited
OTC Pink: Yield Sign
Net Revenues: $13,642,000
Gross Profit: $3,477,000
Operating Income: $-612,000
Net Income: $-1,219,000
Property Plant and Equipment: $56,000
Cash on Hand: $289,000
Cash on Hand Days: 26.6 Days
Scripts: 180,000
Authorized Shares: 500 million
Outstanding Shares: 352 million
Share price: $0.038
Highlights:
Last of 3(a)(10) transactions were completed in December 2015, eliminating nearly 2 million in aged debt off the balance sheet.
2016
Financials: Audited, with Quarterly Reviews by Auditing Firm
OTC Pink: Current Information Tier
Net Revenues: $18,318,000 - 34% Increase
Gross Profit: $5,059,000 - $1,582,000 Increase
Operating Income: $232,000 - $844,000 Increase
Net Income: $209,000 aka. Profitable with $1,428,000 Increase
Property Plant and Equipment: $350,000 Increase of nearly $300,000. Oh here’s where some additional profit went.
Cash on Hand: $816,000 - $527 Increase
Cash on Hand Days: 62.6 Days - 36 Days Increase
Scripts: 213,400 - 20% Increase
Authorized Shares: 500 million - No Change
Outstanding Shares: 344 million - Decrease of 8 million
Share price: $0.0185 - I guess this means we are heavily undervalued after the aforementioned improvements in performance.
Highlights:
Quarterly Conference Calls with Investors
Completion of Warehouse space expansion.
Installation of Script Pro automation system (1000 scripts per day capacity)
Started Smart Medical Alliance, healthcare consulting company
Became the primary 340B pharmacy for Empower U
2017 Additional Highlights:
Opened Resource Center in Century Villiage
Signed 340B Agreement with Community Aids Network
Released Audited Financials for FY2016 Timely
If Pete and Repeat are in a boat and Pete falls out, who's left? Answer: If Pete and Repeat are in a boat and Pete falls out, who's left?
